Company profile: Touchlight
1.1 - Company Overview
Company description
- Provider of a DNA production platform and services for developing DNA vaccines in oncology and infectious diseases. Offers dbDNA synthetic DNA vector technology with enzymatic manufacturing for high-speed, scalable, high-purity DNA; contract manufacturing including GMP dbDNA for advanced therapy medicinal product manufacture; pre-clinical, development, and regulatory support.
Products and services
- GMP dbDNA™: Produces dbDNA™ compliant with Good Manufacturing Practice standards for use in advanced therapy medicinal product manufacture in oncology and infectious diseases
- GMP-compliant
- DbDNA™ technology: Engineers a synthetic DNA vector and enzymatic manufacturing process to produce DNA at high speed, large scale, and high purity for oncology and infectious disease vaccines
- Industrial-grade
- DNA Manufacturing Services: Delivers contract development and manufacturing to produce dbDNA™ as critical starting material or active pharmaceutical ingredient for oncology and infectious disease DNA vaccine programs
- Custom-engineered
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Touchlight
Palamedrix
HQ: United States
Website
- Description: Provider of a multi-omic platform leveraging DNA nanotechnology to deliver comprehensive data for biomedical applications, accelerating advancements in life science and medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Palamedrix company profile →
Catalog
HQ: United States
Website
- Description: Provider of a data conversion and storage platform used to offer next-generation digital data archives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Catalog company profile →
BridgeBio Pharma
HQ: United States
Website
- Description: Provider of precision medicines for genetic diseases and cancers, developing assets including BBP-398 (SHP2 inhibitor for MAPK/RAS-driven cancers), BBP-631 (AAV5 gene therapy for congenital adrenal hyperplasia), BBP-818 (AAV gene therapy for classic galactosemia), BBP-589 (recombinant collagen 7 for dystrophic epidermolysis bullosa), BBP-681 (topical PI3KA inhibitor), and BBP-711 (GO inhibitor).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BridgeBio Pharma company profile →
Eligo Bioscience
HQ: France
Website
- Description: Provider of CRISPR/Cas and engineered phage capsid-based antimicrobials and microbiome editing technologies to control bacterial ecosystems in humans and animals. Solutions include the GEM platform for in vivo gene editing, SSAM sequence-specific antimicrobials, FAME for therapeutic gene addition, and capabilities for gene removal, modification, and addition to eradicate resistant pathogens and modulate disease mechanisms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eligo Bioscience company profile →
HomeDNA
HQ: United States
Website
- Description: Provider of a home paternity test kit; a pharmaceutical firm.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HomeDNA company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Touchlight
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Touchlight
2.2 - Growth funds investing in similar companies to Touchlight
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Touchlight
4.2 - Public trading comparable groups for Touchlight
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →